Clinical Trial Update: Study of the Efficacy and Safety of NPC-15 for Sleep Disorders of Children With Neurodevelopmental Disorders [Phase 3]

View source ↗

Summary

Phase 3 clinical trial assessing NPC-15 for sleep disorders in children with neurodevelopmental disorders has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neurodevelopmental Disorder
• Sleep Disorders

Drugs mentioned

• NPC-15

Snippet

Sponsor: Nobelpharma | Conditions: Sleep Disorders, Neurodevelopmental Disorder | Phase 3 | Status: COMPLETED